Global Optic Neuritis Market Size, Trends, and Growth Opportunity, By Type (Oral Corticosteroids, Intravenous Corticosteroids), Applications (Paediatric Use, Geriatric Use), End-User (Hospitals, Research Institutes, Specialty Clinics),  Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, and Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa ) and Forecast till 2030.
Global Optic Neuritis Market 
The Global Optic Neuritis Market was valued at USD 205.9  million in 2022 and is expected to expand to USD 304.8 million in 2030 at a CAGR of 5.02 % during the forecast period 2023- 2030.
Optic neuritis is a type of nerve injury caused by a high blood sugar level in the body. The symptoms can begin with pain and numbness in the legs and feet and progress to the urinary system, blood vessels, and heart. It is a form of diabetes complication that can affect diabetics. Optic neuritis is a serious and prevalent long-term complication of type 1 and type 2 diabetes.
Market Drivers
 The growing demand for therapy segments like steroidal therapy, vitamin supplementation therapy, and Immunomodulators therapy act as major factors in growing the optic neuritis market. 
The changing lifestyle propelled market growth in the forecast period. Additionally, the increased consumption of cigarette smoking increases the incidence of optic neuritis disease boosts the growth optic neuritis market.
Market Restraints
The high cost associated with the treatment hinders the growth of the optic neuritis market.
Furthermore, the strict government regulatory policies on optic neuritis restrain the market growth.
COVID-19 Impact on Optic Neuritis Market 
The outbreak of covid-19 shows a positive significant impact on the market the as the covid-19 infection increases the incidences of optical neuritis. The cancellation of ophthalmology services because of lockdown restrictions impacted the market to some extent.
Impact of Russia Ukraine War on the Market
The conflict between Russia and Ukraine can have both direct and indirect impacts on the optic neuritis market:
Disruptions in the supply chain: Many optic neuritis manufacturers source components from Russia and Ukraine. The war may cause supply chain disruptions and delays, affecting non-steroidal anti-inflammatory drug production and delivery.
Economic sanctions: Economic sanctions imposed on Russia may have an impact on the overall economy, as well as the demand for optic neuritis in the region.
Market Segmentation 
The Global Optic Neuritis Market is segmented on the basis of Type, Application, Distribution Channel, End-User, and Region. Based on Type, it is segmented into Oral Corticosteroids, Intravenous Corticosteroids. Based on the Application, it is segmented into Paediatric Use, Geriatric Use. On the basis of End-User, it is segmented into Hospitals, Research Institutes, and Specialty Clinics. Based on the Distribution Channel, it is segmented into Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, and Others. On the basis of Region, it is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. 
Regional Analysis
North America is likely to dominate the market over the forecast period due to the presence of more key manufacturers of the product and growing research and development activities in this region.
Asia-Pacific is also anticipated to witness substantial growth due to growing technological advancement in this region.
Key Players 
Various key players are listed in this report such as Aerie Pharmaceuticals Inc, Bausch Health Companies Inc, Merck & Co Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, EyePoint Pharmaceuticals Inc, Amorphex Therapeutics Holdings Inc, Kubota Vision Inc, Alcon Vision LLC Ellex Medical, Lumenis Be Ltd, Acorn Biomedical Inc, Astellas Pharma Inc, Glenmark Pharmaceuticals Ltd, Bayer AG, and Novartis AG.
Market Taxonomy
By Type
• Oral Corticosteroids
• Intravenous Corticosteroids 
By Application
• Pediatric Use
• Geriatric Use
By End-User 
• Hospitals
• Research Institutes
• Specialty Clinics 

By Distribution Channel 
• Hospital Pharmacy
• Retail Pharmacy
• online Pharmacies 
• Others 
By Region 
• North America
• Europe
• Asia Pacific   
• Latin America
• Middle East and Africa
   Key Question Addressed by the Report
• What are the Key Opportunities in Global Optic Neuritis Market?
• What will be the growth rate from 2023 to 2030?
• Which segment/region will have the highest growth?
• What are the factors that will impact/drive the Market?
• What is the role of key players in the value chain?
           

Global Optic Neuritis Market  
1 Introduction 
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Optic Neuritis Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn 
4.2.6 Post covid-19 world Supply& Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Optic Neuritis Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Global Optic Neuritis Market Share Analysis, By Type
5.3 Global Optic Neuritis Market Size and Forecast, By Type
5.3.1 Oral Corticosteroids
5.3.2 Intravenous Corticosteroids 
6 Global Optic Neuritis Market, By Applications
6.1 Y-o-Y Growth Comparison, By Applications
6.2 Global Optic Neuritis Market Share Analysis, By Applications
6.3 Global Optic Neuritis Market Size and Forecast, By Applications
6.3.1 Paediatric Use
6.3.2 Geriatric Use 
7 Global Optic Neuritis Market, By Distribution Channel
7.1 Y-o-Y Growth Comparison, By Distribution Channel
7.2 Global Optic Neuritis Market Share Analysis, By Distribution Channel
7.3 Global Optic Neuritis Market Size and Forecast, By Distribution Channel 
7.3.1 Hospital Pharmacy
7.3.2 Retail Pharmacy
7.3.3 Online Pharmacies
7.3.4 Others 
8 Global Optic Neuritis Market, By End-Users
8.1 Y-o-Y Growth Comparison, By End-Users 
8.2 Global Optic Neuritis Market Share Analysis, By End-Users 
8.3 Global Optic Neuritis Market Size and Forecast, By End-Users 
8.3.1 Hospitals
8.3.2 Research Institutes
8.3.3 Specialty Clinics 
9 Global Optic Neuritis Market, By Region
9.1 Global Optic Neuritis Market Share Analysis, By Region
9.2 Global Optic Neuritis Market Size and Forecast, By Region
10 North America Optic Neuritis Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 North America Optic Neuritis Market Share Analysis, By Type
10.3 North America Optic Neuritis Size and Forecast, By Applications
10.4 North America Optic Neuritis Market Size and Forecast, By Distribution Channel
10.5 North America Optic Neuritis Market Size and Forecast, By End-Users 
10.6 North America Optic Neuritis Market Size and Forecast, By Country
10.6.1 U.S
10.6.2 Canada
10.6.3 Mexico
11 Europe Optic Neuritis Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Europe Optic Neuritis Market Share Analysis, By Type
11.3 Europe Optic Neuritis Market Size and Forecast, By Applications
11.4 Europe Optic Neuritis Market Size and Forecast, By Distribution Channel
11.5 Europe Optic Neuritis Market Size and Forecast, By End-Users 
11.6 Europe Optic Neuritis Market Size and Forecast, By Country
11.6.1 Germany
11.6.2 France
11.6.3 UK
11.6.4 Rest of Europe
12 Asia Pacific Optic Neuritis Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Asia-Pacific Optic Neuritis Market Size and Forecast, By Type
12.3 Asia-Pacific Optic Neuritis Market Size and Forecast, By Applications 
12.4 Asia-Pacific Optic Neuritis Market Size and Forecast, By Distribution Channel
12.5 Asia-Pacific Optic Neuritis Market Size and Forecast, By End-Users 
12.6 Asia-Pacific Optic Neuritis Market Size and Forecast, By Country
12.6.1 China 
12.6.2 Japan
12.6.3 India
12.6.4. Rest of Asia Pacific
13 Latin America Optic Neuritis Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Latin America Optic Neuritis Market Size and Forecast, By Type
13.3 Latin America Optic Neuritis Market Size and Forecast, By Applications
13.4 Latin America Optic Neuritis Market Size and Forecast, By Distribution Channel
13.5 Latin America Optic Neuritis Market Size and Forecast, By End-Users 
13.6 Latin America Optic Neuritis Market Size and Forecast, By Country
13.6.1 Brazil
13.6.2.Rest of Latin America
14 Middle East Optic Neuritis Market Analysis and Forecast (2023-2030)
14.1 Introduction
14.2 Middle East Optic Neuritis Market Share Analysis, By Type
14.3 Middle East Optic Neuritis Market Size and Forecast, By Applications
14.4 Middle East Optic Neuritis Market Size and Forecast, By Distribution Channel   
14.5 Middle East Optic Neuritis Market Size and Forecast, By End-Users 
14.6 Middle East Optic Neuritis Market Size and Forecast, By Country
14.6.1. Saudi Arabia
14.6.2. UAE
14.6.3. Egypt
14.6.4. Kuwait
14.6.5. South Africa
15 Competitive Analysis
15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies
16 Company Profiles
16.1. Aerie Pharmaceuticals Inc 
16.1.1 Overview
16.1.2 Offerings
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2. Bausch Health Companies Inc
16.2.1 Overview
16.2.2 Offerings
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3. Merck & Co Inc
16.3.1 Overview
16.3.2 Offerings
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4. Pfizer Inc 
16.4.1 Overview
16.4.2 Offerings
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6   Key Strategies
16.5.  Teva Pharmaceutical Industries Ltd
16.5.1 Overview
16.5.2 Offerings
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategies
16.6. EyePoint Pharmaceuticals Inc
16.6.1 Overview
16.6.2 Offerings
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6  Key Strategies
16.7. Amorphex Therapeutics Holdings Inc
16.7.1 Overview
16.7.2 Offerings
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies
16.8. Kubota Vision Inc
16.8.1 Overview
16.8.2 Offerings
16.8.3 Key Financials
16.8.4 Business Segment & Geographic Overview
16.8.5 Key Market Developments
16.8.6 Key Strategies
16.9. Alcon Vision LLC Ellex Medical 
16.9.1 Overview
16.9.2 Offerings
16.9.3 Key Financials
16.9.4 Business Segment & Geographic Overview
16.9.5Key Market Developments
16.9.6 Key Strategies
16.10. Lumenis Be Ltd
16.10.1 Overview
16.10.2 Offerings
16.10.3 Key Financials
16.10.4 Business Segment & Geographic Overview
16.10.5 Key Market Developments
16.10.6 Key Strategies
16.11. Acorn Biomedical Inc
16.11.1 Overview
16.11.2 Offerings
16.11.3 Key Financials
16.11.4 Business Segment & Geographic Overview
16.11.5 Key Market Developments
16.11.6 Key Strategies
16.12. Astellas Pharma Inc 
16.12.1 Overview
16.12.2 Offerings
16.12.3 Key Financials
16.12.4 Business Segment & Geographic Overview
16.12.5 Key Market Developments
16.12.6 Key Strategies
16.13. Glenmark Pharmaceuticals Ltd 
16.13.1 Overview
16.13.2 Offerings
16.13.3 Key Financials
16.13.4 Business Segment & Geographic Overview
16.13.5 Key Market Developments
16.13.6 Key Strategies
16.14. Bayer AG
16.14.1 Overview
16.14.2 Offerings
16.14.3 Key Financials
16.14.4 Business Segment & Geographic Overview
16.14.5 Key Market Developments
16.14.6 Key Strategies
16.15. Novartis AG
16.15.1 Overview
16.15.2 Offerings
16.15.3 Key Financials
16.15.4 Business Segment & Geographic Overview
16.15.5 Key Market Developments
16.15.6 Key Strategies